BlackRock
ALBO

BlackRock’s Albireo Pharma Inc ALBO Stock Holding History

BlackRock’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,344,897
Closed -$29.1M – 5789
2022
Q4 		$29.1M Buy
1,344,897
+129,491
+11% +$2.74M ﹤0.01% 2821
2022
Q3 		$23.5M Buy
1,215,406
+2,786
+0.2% +$57.6K ﹤0.01% 2944
2022
Q2 		$24.1M Buy
1,212,620
+61,588
+5% +$1.62M ﹤0.01% 2990
2022
Q1 		$34.3M Sell
1,151,032
-17,751
-2% -$520K ﹤0.01% 2813
2021
Q4 		$27.2M Buy
1,168,783
+11,917
+1% +$317K ﹤0.01% 3082
2021
Q3 		$36.1M Sell
1,156,866
-41,956
-3% -$1.3M ﹤0.01% 2879
2021
Q2 		$42.2M Sell
1,198,822
-79,912
-6% -$2.6M ﹤0.01% 2809
2021
Q1 		$45.1M Buy
1,278,734
+35,954
+3% +$1.33M ﹤0.01% 2686
2020
Q4 		$46.6M Buy
1,242,780
+305,624
+33% +$11.1M ﹤0.01% 2521
2020
Q3 		$31.3M Buy
937,156
+27,727
+3% +$808K ﹤0.01% 2588
2020
Q2 		$24.1M Buy
909,429
+140,806
+18% +$3.32M ﹤0.01% 2703
2020
Q1 		$12.6M Buy
768,623
+59,242
+8% +$1.3M ﹤0.01% 2872
2019
Q4 		$18M Buy
709,381
+33,916
+5% +$678K ﹤0.01% 2936
2019
Q3 		$13.5M Buy
675,465
+16,698
+3% +$432K ﹤0.01% 3043
2019
Q2 		$21.2M Buy
658,767
+84,575
+15% +$2.83M ﹤0.01% 2810
2019
Q1 		$18.5M Sell
574,192
-11,309
-2% -$304K ﹤0.01% 2781
2018
Q4 		$14.4M Buy
585,501
+1,324
+0.2% +$35K ﹤0.01% 2902
2018
Q3 		$19.3M Buy
584,177
+59,901
+11% +$1.96M ﹤0.01% 2890
2018
Q2 		$18.6M Buy
524,276
+447,496
+583% +$14.5M ﹤0.01% 2905
2018
Q1 		$2.5M Buy
76,780
+64,444
+522% +$2.17M ﹤0.01% 3622
2017
Q4 		$316K Buy
12,336
+1,375
+13% +$34.9K ﹤0.01% 4120
2017
Q3 		$229K Buy
10,961
+1,955
+22% +$46.6K ﹤0.01% 4199
2017
Q2 		$186K Buy
9,006
+8,126
+923% +$167K ﹤0.01% 4267
2017
Q1 		$21K Buy
+880
New +$19.1K ﹤0.01% 4613

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BlackRock's ALBO Position: Q1 2023 in Review

BlackRock sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 1,344,897 shares — an estimated $29.1M sold.

BlackRock first reported a position in ALBO in Q1 2017 and held it in 24 quarters. The position peaked at $46.6M in Q4 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • BlackRock reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • BlackRock sold 1,344,897 Albireo Pharma Inc shares in Q1 2023, an estimated $29.1M.
  • BlackRock first reported a position in Albireo Pharma Inc in Q1 2017 and held it in 24 quarters.
  • BlackRock's Albireo Pharma Inc position peaked at $46.6M in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on BlackRock's 13F filing for Q1 2023, filed 12 May 2023.